Compositions and methods for bacterial delivery of polypeptides
AssigneesThe General Hospital Corporation, President and Fellows of Harvard College
InventorsCammie LESSER, Amy Jo Wagers, Analise Z. Reeves
Life of this patent
Estimating the term…
Abstract
The methods and compositions described herein relate to the delivery of polypeptides to a target cell, e.g. by utilizing engineered non-pathogenic bacteria comprising a type three secretion system (T3SS) and T3SS-compatible substrates. In one aspect, described herein are non-pathogenic microbial cells that have been engineered to express both a functional type three secretion system (T3SS) and at least one polypeptide that is compatible with the T3SS. Due to the wide variety of polypeptides that can be delivered to a target eukaryotic cell using the compositions and systems described herein, a commensurately wide variety of applications is contemplated, e.g. therapeutics and reprogramming.
Claims2
An engineered non-pathogenic microbial cell comprising:
- a first nucleic acid sequence comprising genes encoding a functional type three secretion system (T3SS);
- a second nucleic acid sequence encoding an T3SS-compatible polypeptide;
- wherein the engineered microbial cell is non-pathogenic with respect to the target cell or target organism.
-56. (canceled)
Dependencies are inferred from the claim text.